124 related articles for article (PubMed ID: 22336524)
1. [Post-menopausal ovarian hyperthecosis].
Castell AL; Hieronimus S; Chevallier A; Sadoul JL; Galand-Portier MB; Delotte J; Fénichel P
Gynecol Obstet Fertil; 2012 May; 40(5):316-9. PubMed ID: 22336524
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome after menopause: a case report.
Pauli S; Lobo RA
J Reprod Med; 2004 Jun; 49(6):491-4. PubMed ID: 15283061
[TBL] [Abstract][Full Text] [Related]
3. Cell adhesion and apoptosis in ovarian stromal hyperplasia and hyperthecosis.
Sharabidze N; Burkadze G; Sabakhtarashvili M
Georgian Med News; 2006 Feb; (131):33-7. PubMed ID: 16575127
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
5. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and apoptosis in ovarian stromal hyperplasia and hyperthecosis.
Sharabidze N; Sabakhtarashvili M; Burkadze G
Georgian Med News; 2005 Dec; (129):26-9. PubMed ID: 16444023
[TBL] [Abstract][Full Text] [Related]
7. [Hyperthecosis ovarii--a tumor-like change in androgenized females].
Schwartz U; Moltz L; Pickartz H; Sörensen R; Römmler A
Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):391-7. PubMed ID: 3091442
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic hyperandrogenism and/or administered central nervous system insulin on ovarian manifestation and gonadotropin and steroid secretion.
Allon MA; Leach RE; Dunbar J; Diamond MP
Fertil Steril; 2005 Apr; 83 Suppl 1():1319-26. PubMed ID: 15831308
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.
Barbieri RL; Hornstein MD
Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
Poretsky L; Piper B
Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
[TBL] [Abstract][Full Text] [Related]
12. Value of selective venous catheterization in the diagnosis of hyperandrogenism.
Hickman LC; Goodman L; Falcone T
Fertil Steril; 2017 Dec; 108(6):1085. PubMed ID: 29100622
[TBL] [Abstract][Full Text] [Related]
13. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in a patient with ovarian stromal hyperthecosis and the hyperandrogenism, insulin resistance and acanthosis nigricans syndrome. Report of a case with a possible endogenous ovarian factor.
Mantzoros CS; Lawrence WD; Levy J
J Reprod Med; 1995 Jun; 40(6):491-4. PubMed ID: 7650669
[TBL] [Abstract][Full Text] [Related]
15. A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization.
Chico A; García JL; Matías-Guiu X; Webb SM; Rodríguez J; Prat J; Calaf J
Clin Endocrinol (Oxf); 1995 Nov; 43(5):645-9. PubMed ID: 8548951
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
17. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
Barbieri RL
J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
